4-Hour Virtual Seminar on Phase I GMPs

If you are unable to see the message below, [click here to view](. [Logo]( 4-Hour Virtual Seminar [4-Hour Virtual Seminar on Phase I GMPs]( [REGISTER NOW]( This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Date: Thursday, December 12, 2019 Time: 08:00 AM PST | 11:00 AM EST Duration: 4 Hours Instructor: Peggy Berry Overview: Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs. [Read more..](. Who Will Benefit: - Directors - Managers - Supervisors in Regulatory Affairs - Manufacturing - Quality Assurance - Clinical Operations About Speaker: Peggy Berry President & CEO, Synergy Consulting Peggy J. Berry MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. [Read More]( GlobalCompliancePanel 39658 Mission Boulevard, Fremont, CA 94539, USA. Toll Free: +1-800-447-9407 Fax: 302 288 6884 [www.globalcompliancepanel.com]( | [Unsubscribe]( Copyright © 2019 GlobalCompliancePanel. All rights reserved.